Master bibliography — retinoblastoma

Last curated: 2026-09-01

Coverage: 367 unique PubMed records cited across 19 wiki pages. Every PMID below was retrieved live from PubMed E-utilities on 2026-09-01 and re-fetched live during the independent audit on 2026-09-01.

Foundations, epidemiology and diagnosis

• Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 1971;68:820-3. PMID 5279523 — tags: [molecular-pathogenesis-and-cell-of-origin, overview, rb1-genetics-and-heritability] — cited by: molecular-pathogenesis-and-cell-of-origin.md, overview.md, rb1-genetics-and-heritability.md
• Dimaras H, et al. Retinoblastoma. Nature reviews. Disease primers. 2015;1:15021. PMID 27189421 — tags: [clinical-presentation-and-diagnosis, epidemiology-and-global-burden, genetic-testing-and-counselling, global-access-and-outcome-disparity, guidelines, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin, overview, rb1-genetics-and-heritability, red-flags-and-safety-concerns, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, genetic-testing-and-counselling.md, global-access-and-outcome-disparity.md, guidelines.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md, overview.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Global Retinoblastoma Study Group. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. The Lancet. Global health. 2022;10:e1128-e1140. PMID 35839812 — tags: [classification-and-staging, clinical-presentation-and-diagnosis, clinical-trials-landscape, enucleation-and-high-risk-pathology, epidemiology-and-global-burden, extraocular-metastatic-and-trilateral-disease, focal-therapy-and-brachytherapy, genetic-testing-and-counselling, global-access-and-outcome-disparity, guidelines, intra-arterial-chemotherapy, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin, overview, rb1-genetics-and-heritability, red-flags-and-safety-concerns, second-cancers-and-survivorship, systemic-chemotherapy, vision-outcomes-and-patient-experience] — cited by: classification-and-staging.md, clinical-presentation-and-diagnosis.md, clinical-trials-landscape.md, enucleation-and-high-risk-pathology.md, epidemiology-and-global-burden.md, extraocular-metastatic-and-trilateral-disease.md, focal-therapy-and-brachytherapy.md, genetic-testing-and-counselling.md, global-access-and-outcome-disparity.md, guidelines.md, intra-arterial-chemotherapy.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md, overview.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, systemic-chemotherapy.md, vision-outcomes-and-patient-experience.md
• Schonfeld SJ, et al. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors. British journal of cancer. 2021;124:1312-1319. PMID 33473166 — tags: [overview, rb1-genetics-and-heritability, second-cancers-and-survivorship] — cited by: overview.md, rb1-genetics-and-heritability.md, second-cancers-and-survivorship.md
• Nag A, et al. Retinoblastoma - A comprehensive review, update and recent advances. Indian journal of ophthalmology. 2024;72:778-788. PMID 38804799 — tags: [extraocular-metastatic-and-trilateral-disease, focal-therapy-and-brachytherapy, genetic-testing-and-counselling, guidelines, intravitreal-and-intracameral-chemotherapy, overview, rb1-genetics-and-heritability, second-cancers-and-survivorship, systemic-chemotherapy, vision-outcomes-and-patient-experience] — cited by: extraocular-metastatic-and-trilateral-disease.md, focal-therapy-and-brachytherapy.md, genetic-testing-and-counselling.md, guidelines.md, intravitreal-and-intracameral-chemotherapy.md, overview.md, rb1-genetics-and-heritability.md, second-cancers-and-survivorship.md, systemic-chemotherapy.md, vision-outcomes-and-patient-experience.md
• Rao R, et al. Retinoblastoma. Indian journal of pediatrics. 2017;84:937-944. PMID 28620731 — tags: [clinical-presentation-and-diagnosis, focal-therapy-and-brachytherapy, guidelines, overview, red-flags-and-safety-concerns, second-cancers-and-survivorship, systemic-chemotherapy, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, focal-therapy-and-brachytherapy.md, guidelines.md, overview.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, systemic-chemotherapy.md, vision-outcomes-and-patient-experience.md
• Ortiz MV, et al. Retinoblastoma. Journal of child neurology. 2016;31:227-36. PMID 26023180 — tags: [classification-and-staging, clinical-presentation-and-diagnosis, epidemiology-and-global-burden, extraocular-metastatic-and-trilateral-disease, global-access-and-outcome-disparity, intra-arterial-chemotherapy, overview, red-flags-and-safety-concerns, second-cancers-and-survivorship] — cited by: classification-and-staging.md, clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, extraocular-metastatic-and-trilateral-disease.md, global-access-and-outcome-disparity.md, intra-arterial-chemotherapy.md, overview.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md
• Dimaras H, et al. Retinoblastoma. Lancet (London, England). 2012;379:1436-46. PMID 22414599 — tags: [clinical-presentation-and-diagnosis, epidemiology-and-global-burden, genetic-testing-and-counselling, global-access-and-outcome-disparity, guidelines, overview, rb1-genetics-and-heritability, red-flags-and-safety-concerns, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, genetic-testing-and-counselling.md, global-access-and-outcome-disparity.md, guidelines.md, overview.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Kumari A, et al. A Comprehensive Review of the Epidemiology, Pathophysiology, Risk Factors, and Treatment Strategies for Retinoblastoma. Diseases (Basel, Switzerland). 2025;13. PMID 41002743 — tags: [overview, second-cancers-and-survivorship] — cited by: overview.md, second-cancers-and-survivorship.md
• Singh L, et al. Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus Guidelines. Indian journal of pediatrics. 2024;91:1147-1156. PMID 38492167 — tags: [classification-and-staging, enucleation-and-high-risk-pathology, epidemiology-and-global-burden, genetic-testing-and-counselling, guidelines, intra-arterial-chemotherapy, overview, rb1-genetics-and-heritability, second-cancers-and-survivorship] — cited by: classification-and-staging.md, enucleation-and-high-risk-pathology.md, epidemiology-and-global-burden.md, genetic-testing-and-counselling.md, guidelines.md, intra-arterial-chemotherapy.md, overview.md, rb1-genetics-and-heritability.md, second-cancers-and-survivorship.md
• Lin FY, et al. Neonatal Retinoblastoma. Clinics in perinatology. 2021;48:53-70. PMID 33583507 — tags: [clinical-presentation-and-diagnosis, genetic-testing-and-counselling, global-access-and-outcome-disparity, guidelines, overview, rb1-genetics-and-heritability, red-flags-and-safety-concerns, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, genetic-testing-and-counselling.md, global-access-and-outcome-disparity.md, guidelines.md, overview.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Sengupta S, et al. Adult onset retinoblastoma. Indian journal of ophthalmology. 2016;64:485-91. PMID 27609158 — tags: [clinical-presentation-and-diagnosis, guidelines, overview, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, guidelines.md, overview.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Roy SR, et al. Retinoblastoma: A Major Review. Mymensingh medical journal : MMJ. 2021;30:881-895. PMID 34226484 — tags: [epidemiology-and-global-burden, overview, second-cancers-and-survivorship] — cited by: epidemiology-and-global-burden.md, overview.md, second-cancers-and-survivorship.md
• Manrique M, et al. Update on the Treatment of Retinoblastoma. NeoReviews. 2021;22:e423-e437. PMID 34210807 — tags: [genetic-testing-and-counselling, overview, rb1-genetics-and-heritability, second-cancers-and-survivorship] — cited by: genetic-testing-and-counselling.md, overview.md, rb1-genetics-and-heritability.md, second-cancers-and-survivorship.md
• AlAli A, et al. Retinoblastoma for Pediatric Ophthalmologists. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2018;7:160-168. PMID 29737052 — tags: [classification-and-staging, clinical-presentation-and-diagnosis, epidemiology-and-global-burden, extraocular-metastatic-and-trilateral-disease, global-access-and-outcome-disparity, overview, red-flags-and-safety-concerns] — cited by: classification-and-staging.md, clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, extraocular-metastatic-and-trilateral-disease.md, global-access-and-outcome-disparity.md, overview.md, red-flags-and-safety-concerns.md
• Bornfeld N, et al. [Retinoblastoma]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2006;103:59-76; quiz 77-8. PMID 16382314 — tags: [overview] — cited by: overview.md
• Raval V, et al. Cavitary retinoblastoma: A review of literature. Survey of ophthalmology. 2022;67:723-728. PMID 34648817 — tags: [overview] — cited by: overview.md
• Abramson DH, et al. Update on retinoblastoma. Retina (Philadelphia, Pa.). 2004;24:828-48. PMID 15579980 — tags: [overview] — cited by: overview.md
• Aerts I, et al. [Retinoblastoma update]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 2016;23:112-6. PMID 26679524 — tags: [epidemiology-and-global-burden, focal-therapy-and-brachytherapy, genetic-testing-and-counselling, overview, rb1-genetics-and-heritability] — cited by: epidemiology-and-global-burden.md, focal-therapy-and-brachytherapy.md, genetic-testing-and-counselling.md, overview.md, rb1-genetics-and-heritability.md
• Global Retinoblastoma Study Group, et al. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA oncology. 2020;6:685-695. PMID 32105305 — tags: [extraocular-metastatic-and-trilateral-disease, global-access-and-outcome-disparity, overview] — cited by: extraocular-metastatic-and-trilateral-disease.md, global-access-and-outcome-disparity.md, overview.md
• Fabian ID, et al. The management of retinoblastoma. Oncogene. 2018;37:1551-1560. PMID 29321667 — tags: [clinical-presentation-and-diagnosis, genetic-testing-and-counselling, global-access-and-outcome-disparity, guidelines, overview, rb1-genetics-and-heritability, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, genetic-testing-and-counselling.md, global-access-and-outcome-disparity.md, guidelines.md, overview.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md
• Ray A, et al. Retinoblastoma: an overview. Indian journal of pediatrics. 2012;79:916-21. PMID 22421935 — tags: [classification-and-staging, overview] — cited by: classification-and-staging.md, overview.md
• Singh AD. Retinoblastoma: What is the future? International ophthalmology clinics. 2019;59:95-99. PMID 30908283 — tags: [overview] — cited by: overview.md
• Jehanne M, et al. [Retinoblastoma: recent advances]. Bulletin du cancer. 2014;101:380-7. PMID 24793631 — tags: [focal-therapy-and-brachytherapy, genetic-testing-and-counselling, overview, rb1-genetics-and-heritability] — cited by: focal-therapy-and-brachytherapy.md, genetic-testing-and-counselling.md, overview.md, rb1-genetics-and-heritability.md
• Kayembe L. [Retinoblastoma: 21-year review]. Journal francais d'ophtalmologie. 1986;9:561-5. PMID 3819329 — tags: [overview] — cited by: overview.md
• Fabius AWM, et al. Subsequent Malignant Neoplasms in Retinoblastoma Survivors. Cancers. 2021;13. PMID 33801943 — tags: [overview, second-cancers-and-survivorship] — cited by: overview.md, second-cancers-and-survivorship.md
• Byroju VV, et al. Retinoblastoma: present scenario and future challenges. Cell communication and signaling : CCS. 2023;21:226. PMID 37667345 — tags: [epidemiology-and-global-burden, focal-therapy-and-brachytherapy, genetic-testing-and-counselling, global-access-and-outcome-disparity, guidelines, overview, rb1-genetics-and-heritability, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: epidemiology-and-global-burden.md, focal-therapy-and-brachytherapy.md, genetic-testing-and-counselling.md, global-access-and-outcome-disparity.md, guidelines.md, overview.md, rb1-genetics-and-heritability.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Ancona-Lezama D, et al. Modern treatment of retinoblastoma: A 2020 review. Indian journal of ophthalmology. 2020;68:2356-2365. PMID 33120616 — tags: [classification-and-staging, focal-therapy-and-brachytherapy, genetic-testing-and-counselling, guidelines, intra-arterial-chemotherapy, overview, second-cancers-and-survivorship, systemic-chemotherapy, vision-outcomes-and-patient-experience] — cited by: classification-and-staging.md, focal-therapy-and-brachytherapy.md, genetic-testing-and-counselling.md, guidelines.md, intra-arterial-chemotherapy.md, overview.md, second-cancers-and-survivorship.md, systemic-chemotherapy.md, vision-outcomes-and-patient-experience.md
• Zhou M, et al. Recent progress in retinoblastoma: Pathogenesis, presentation, diagnosis and management. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024;13:100058. PMID 38615905 — tags: [classification-and-staging, clinical-presentation-and-diagnosis, epidemiology-and-global-burden, genetic-testing-and-counselling, global-access-and-outcome-disparity, guidelines, molecular-pathogenesis-and-cell-of-origin, overview, rb1-genetics-and-heritability, red-flags-and-safety-concerns, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: classification-and-staging.md, clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, genetic-testing-and-counselling.md, global-access-and-outcome-disparity.md, guidelines.md, molecular-pathogenesis-and-cell-of-origin.md, overview.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Warda O, et al. Retinoblastoma and vision. Eye (London, England). 2023;37:797-808. PMID 34987197 — tags: [guidelines, overview, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: guidelines.md, overview.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Rodriguez-Galindo C, et al. Retinoblastoma. Pediatric clinics of North America. 2015;62:201-23. PMID 25435120 — tags: [genetic-testing-and-counselling, guidelines, molecular-pathogenesis-and-cell-of-origin, overview, rb1-genetics-and-heritability, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: genetic-testing-and-counselling.md, guidelines.md, molecular-pathogenesis-and-cell-of-origin.md, overview.md, rb1-genetics-and-heritability.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Melamud A, et al. Retinoblastoma. American family physician. 2006;73:1039-44. PMID 16570739 — tags: [focal-therapy-and-brachytherapy, genetic-testing-and-counselling, guidelines, overview, rb1-genetics-and-heritability, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: focal-therapy-and-brachytherapy.md, genetic-testing-and-counselling.md, guidelines.md, overview.md, rb1-genetics-and-heritability.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Villegas VM, et al. Retinoblastoma. Current opinion in ophthalmology. 2013;24:581-8. PMID 24100372 — tags: [clinical-presentation-and-diagnosis, guidelines, overview, red-flags-and-safety-concerns, second-cancers-and-survivorship, systemic-chemotherapy, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, guidelines.md, overview.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, systemic-chemotherapy.md, vision-outcomes-and-patient-experience.md
• Antoneli CB, et al. Trilateral retinoblastoma. Pediatric blood & cancer. 2007;48:306-10. PMID 16572402 — tags: [epidemiology-and-global-burden, extraocular-metastatic-and-trilateral-disease, guidelines, overview, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: epidemiology-and-global-burden.md, extraocular-metastatic-and-trilateral-disease.md, guidelines.md, overview.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Aerts I, et al. Retinoblastoma. Orphanet journal of rare diseases. 2006;1:31. PMID 16934146 — tags: [clinical-presentation-and-diagnosis, epidemiology-and-global-burden, focal-therapy-and-brachytherapy, genetic-testing-and-counselling, guidelines, molecular-pathogenesis-and-cell-of-origin, overview, rb1-genetics-and-heritability, red-flags-and-safety-concerns, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, focal-therapy-and-brachytherapy.md, genetic-testing-and-counselling.md, guidelines.md, molecular-pathogenesis-and-cell-of-origin.md, overview.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Cassoux N, et al. Retinoblastoma: Update on Current Management. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2017;6:290-295. PMID 28558178 — tags: [guidelines, overview, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: guidelines.md, overview.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Abramson DH, et al. Retinoblastoma. Optometry clinics : the official publication of the Prentice Society. 1993;3:49-61. PMID 8199450 — tags: [clinical-presentation-and-diagnosis, epidemiology-and-global-burden, focal-therapy-and-brachytherapy, global-access-and-outcome-disparity, guidelines, overview, red-flags-and-safety-concerns, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, focal-therapy-and-brachytherapy.md, global-access-and-outcome-disparity.md, guidelines.md, overview.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Mehta M, et al. Retinoblastoma. Singapore medical journal. 2012;53:128-35; quiz 136. PMID 22337189 — tags: [clinical-presentation-and-diagnosis, focal-therapy-and-brachytherapy, global-access-and-outcome-disparity, guidelines, overview, red-flags-and-safety-concerns, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, focal-therapy-and-brachytherapy.md, global-access-and-outcome-disparity.md, guidelines.md, overview.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Servodidio CA, et al. Retinoblastoma. Cancer nursing. 1991;14:117-23. PMID 2059954 — tags: [focal-therapy-and-brachytherapy, guidelines, overview, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: focal-therapy-and-brachytherapy.md, guidelines.md, overview.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Jain M, et al. Retinoblastoma in Asia. Eye (London, England). 2019;33:87-96. PMID 30385881 — tags: [epidemiology-and-global-burden, global-access-and-outcome-disparity, overview, second-cancers-and-survivorship, vision-outcomes-and-patient-experience] — cited by: epidemiology-and-global-burden.md, global-access-and-outcome-disparity.md, overview.md, second-cancers-and-survivorship.md, vision-outcomes-and-patient-experience.md
• Das S, et al. Lag time for diagnosis and treatment in 1120 retinoblastoma children: Analysis from InPOG-RB-19-01. Indian journal of ophthalmology. 2025;73:1124-1131. PMID 40719713 — tags: [clinical-presentation-and-diagnosis, epidemiology-and-global-burden, global-access-and-outcome-disparity, overview, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, global-access-and-outcome-disparity.md, overview.md, red-flags-and-safety-concerns.md
• Pant G, et al. Outcome of extraocular retinoblastoma in a resource limited center from low middle income country. Pediatric hematology and oncology. 2017;34:419-424. PMID 29337595 — tags: [classification-and-staging, epidemiology-and-global-burden, extraocular-metastatic-and-trilateral-disease, global-access-and-outcome-disparity, red-flags-and-safety-concerns] — cited by: classification-and-staging.md, epidemiology-and-global-burden.md, extraocular-metastatic-and-trilateral-disease.md, global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md
• Bishop JO. Retinoblastoma. Pediatric annals. 1979;8:12-33. PMID 372907 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Wong FL, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278:1262-7. PMID 9333268 — tags: [epidemiology-and-global-burden, red-flags-and-safety-concerns, second-cancers-and-survivorship] — cited by: epidemiology-and-global-burden.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md
• Damodharan S, et al. Increased Incidence of Retinoblastoma in Wisconsin: Coincidence or Public Health Concern? WMJ : official publication of the State Medical Society of Wisconsin. 2024;123:76-77. PMID 38718232 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Fabian ID, et al. Understanding retinoblastoma: epidemiology and genetics. Community eye health. 2018;31:7. PMID 29915458 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Cruz-Gálvez CC, et al. Retinoblastoma: Review and new insights. Frontiers in oncology. 2022;12:963780. PMID 36408154 — tags: [clinical-presentation-and-diagnosis, epidemiology-and-global-burden, genetic-testing-and-counselling, molecular-pathogenesis-and-cell-of-origin, rb1-genetics-and-heritability, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, genetic-testing-and-counselling.md, molecular-pathogenesis-and-cell-of-origin.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md
• Pandey AN. Retinoblastoma: An overview. Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. 2014;28:310-5. PMID 25473349 — tags: [clinical-presentation-and-diagnosis, epidemiology-and-global-burden, focal-therapy-and-brachytherapy, guidelines, red-flags-and-safety-concerns, second-cancers-and-survivorship] — cited by: clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, focal-therapy-and-brachytherapy.md, guidelines.md, red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md
• Patel S, et al. Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors. Pediatric blood & cancer. 2021;68 Suppl 2:e28253. PMID 33818883 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Ali MJ, et al. Orbital retinoblastoma: where do we go from here? Journal of cancer research and therapeutics. 2011;7:11-4. PMID 21546735 — tags: [epidemiology-and-global-burden, extraocular-metastatic-and-trilateral-disease] — cited by: epidemiology-and-global-burden.md, extraocular-metastatic-and-trilateral-disease.md
• Virgili G, et al. Survival and Health Care Burden of Children With Retinoblastoma in Europe. JAMA ophthalmology. 2024;142:1062-70. PMID 39388193 — tags: [classification-and-staging, epidemiology-and-global-burden, intra-arterial-chemotherapy, second-cancers-and-survivorship] — cited by: classification-and-staging.md, epidemiology-and-global-burden.md, intra-arterial-chemotherapy.md, second-cancers-and-survivorship.md
• Barbosa AC, et al. Incidence of retinoblastoma in children and adolescents in Brazil: A population-based study. Frontiers in pediatrics. 2022;10:1048792. PMID 36507141 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Friedman DL, et al. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group. Pediatric blood & cancer. 2017;64. PMID 28019092 — tags: [clinical-trials-landscape, epidemiology-and-global-burden, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, epidemiology-and-global-burden.md, systemic-chemotherapy.md
• Chévez-Barrios P, et al. Incidence and Survival Rates in European Children With Retinoblastoma. JAMA ophthalmology. 2024. PMID 39388174 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Sherief ST, et al. Incidence and geographic distribution of retinoblastoma in Ethiopia. BMC ophthalmology. 2023;23:231. PMID 37221479 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Martínez-Sánchez M, et al. Retinoblastoma: from discovery to clinical management. The FEBS journal. 2022;289:4371-4382. PMID 34042282 — tags: [epidemiology-and-global-burden, vision-outcomes-and-patient-experience] — cited by: epidemiology-and-global-burden.md, vision-outcomes-and-patient-experience.md
• Vempuluru VS, et al. Global retinoblastoma studies: A review. Clinical & experimental ophthalmology. 2024;52:334-354. PMID 38263682 — tags: [clinical-presentation-and-diagnosis, epidemiology-and-global-burden, global-access-and-outcome-disparity, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, epidemiology-and-global-burden.md, global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md
• Bhatnagar R, et al. Diffuse infiltrating retinoblastoma. Ophthalmology. 1991;98:1657-61. PMID 1800925 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Mastrangelo D, et al. Retinoblastoma epidemiology: does the evidence matter? European journal of cancer (Oxford, England : 1990). 2007;43:1596-603. PMID 17543516 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Moreno F, et al. A population-based study of retinoblastoma incidence and survival in Argentine children. Pediatric blood & cancer. 2014;61:1610-5. PMID 24729462 — tags: [epidemiology-and-global-burden] — cited by: epidemiology-and-global-burden.md
• Chintagumpala M. Retinoblastoma in Low- and Middle-Income Countries. Pediatric hematology and oncology. 2019;36:53-54. PMID 31195906 — tags: [epidemiology-and-global-burden, global-access-and-outcome-disparity] — cited by: epidemiology-and-global-burden.md, global-access-and-outcome-disparity.md
• Honavar SG. Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries - Can we break the barriers? Indian journal of ophthalmology. 2023;71:325-326. PMID 36727311 — tags: [epidemiology-and-global-burden, global-access-and-outcome-disparity] — cited by: epidemiology-and-global-burden.md, global-access-and-outcome-disparity.md
• Dunkel IJ, et al. Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022;40:3839-3847. PMID 35820112 — tags: [clinical-trials-landscape, epidemiology-and-global-burden, extraocular-metastatic-and-trilateral-disease, global-access-and-outcome-disparity, overview, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, epidemiology-and-global-burden.md, extraocular-metastatic-and-trilateral-disease.md, global-access-and-outcome-disparity.md, overview.md, systemic-chemotherapy.md
• Ramanathan S, et al. Retinoblastoma: Poster-Child Tumor of the Low-Middle Income Countries (LMICs)!!! South Asian journal of cancer. 2022;11:279-280. PMID 36756097 — tags: [epidemiology-and-global-burden, global-access-and-outcome-disparity] — cited by: epidemiology-and-global-burden.md, global-access-and-outcome-disparity.md
• Bouffet E, et al. [Retinoblastoma]. Pediatrie. 1992;47:399-408. PMID 1331956 — tags: [epidemiology-and-global-burden, global-access-and-outcome-disparity] — cited by: epidemiology-and-global-burden.md, global-access-and-outcome-disparity.md
• Finger PT, et al. Retinoblastoma outcomes: a global perspective. The Lancet. Global health. 2022;10:e307-e308. PMID 35093203 — tags: [epidemiology-and-global-burden, global-access-and-outcome-disparity] — cited by: epidemiology-and-global-burden.md, global-access-and-outcome-disparity.md
• Razek AA, et al. MRI of retinoblastoma. The British journal of radiology. 2011;84:775-84. PMID 21849363 — tags: [clinical-presentation-and-diagnosis, extraocular-metastatic-and-trilateral-disease, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, extraocular-metastatic-and-trilateral-disease.md, red-flags-and-safety-concerns.md
• Kletke SN, et al. A typical anterior retinoblastoma: diagnosis by aqueous humor cell-free DNA analysis. Ophthalmic genetics. 2022;43:862-865. PMID 36326029 — tags: [clinical-presentation-and-diagnosis, intravitreal-and-intracameral-chemotherapy] — cited by: clinical-presentation-and-diagnosis.md, intravitreal-and-intracameral-chemotherapy.md
• Kivelä TT, et al. Neonatal Retinoblastoma. Asia-Pacific journal of oncology nursing. 2017;4:197-204. PMID 28695165 — tags: [clinical-presentation-and-diagnosis, extraocular-metastatic-and-trilateral-disease, genetic-testing-and-counselling, molecular-pathogenesis-and-cell-of-origin, rb1-genetics-and-heritability, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, extraocular-metastatic-and-trilateral-disease.md, genetic-testing-and-counselling.md, molecular-pathogenesis-and-cell-of-origin.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md
• Harbour JW. Liquid Biopsy in Retinoblastoma. JAMA ophthalmology. 2017;135:1231. PMID 29049432 — tags: [clinical-presentation-and-diagnosis, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, red-flags-and-safety-concerns.md
• Martínez Arce CA, et al. Update on Retinoblastoma Therapies. Medicina (Kaunas, Lithuania). 2025;61. PMID 40731848 — tags: [clinical-presentation-and-diagnosis, extraocular-metastatic-and-trilateral-disease, genetic-testing-and-counselling, rb1-genetics-and-heritability, red-flags-and-safety-concerns, systemic-chemotherapy] — cited by: clinical-presentation-and-diagnosis.md, extraocular-metastatic-and-trilateral-disease.md, genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md, systemic-chemotherapy.md
• Bornfeld N, et al. [Retinoblastoma]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2020;117:389-402. PMID 32206913 — tags: [clinical-presentation-and-diagnosis, focal-therapy-and-brachytherapy, red-flags-and-safety-concerns, systemic-chemotherapy] — cited by: clinical-presentation-and-diagnosis.md, focal-therapy-and-brachytherapy.md, red-flags-and-safety-concerns.md, systemic-chemotherapy.md
• Verma R, et al. Adult-onset retinoblastoma: An uncommon and challenging diagnosis. Oman journal of ophthalmology. 2023;16:382-384. PMID 37602177 — tags: [clinical-presentation-and-diagnosis, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, red-flags-and-safety-concerns.md
• Jenkinson H. Retinoblastoma: diagnosis and management--the UK perspective. Archives of disease in childhood. 2015;100:1070-5. PMID 25940424 — tags: [classification-and-staging, clinical-presentation-and-diagnosis, red-flags-and-safety-concerns] — cited by: classification-and-staging.md, clinical-presentation-and-diagnosis.md, red-flags-and-safety-concerns.md
• Sanchez GM, et al. Retinoblastoma: Aqueous humor liquid biopsy. Taiwan journal of ophthalmology. 2025;15:55-61. PMID 40213298 — tags: [clinical-presentation-and-diagnosis, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, red-flags-and-safety-concerns.md
• Ademola-Popoola DS, et al. Contemporary management of retinoblastoma in the context of a low-resource country. The Nigerian postgraduate medical journal. 2019;26:69-79. PMID 31187745 — tags: [clinical-presentation-and-diagnosis] — cited by: clinical-presentation-and-diagnosis.md
• Subramaniam S, et al. Presentation of retinoblastoma patients in Malaysia. Asian Pacific journal of cancer prevention : APJCP. 2014;15:7863-7. PMID 25292078 — tags: [clinical-presentation-and-diagnosis] — cited by: clinical-presentation-and-diagnosis.md
• Kao LY, et al. Retinoblastoma in Taiwan: survival and clinical characteristics 1978-2000. Japanese journal of ophthalmology. 2002;46:577-80. PMID 12457919 — tags: [clinical-presentation-and-diagnosis] — cited by: clinical-presentation-and-diagnosis.md
• Hraib M, et al. An atypical clinical/radiological presentation of Retinoblastoma in a 4-year-old child: A case report & educational lessons from Syria. Annals of medicine and surgery (2012). 2022;78:103830. PMID 35734689 — tags: [clinical-presentation-and-diagnosis] — cited by: clinical-presentation-and-diagnosis.md
• Sow AS, et al. [Role of CT in diagnosis and monitoring of retinoblastoma in Senegal]. Journal francais d'ophtalmologie. 2019;42:1085-1089. PMID 31561918 — tags: [clinical-presentation-and-diagnosis] — cited by: clinical-presentation-and-diagnosis.md
• Nelson AJ, et al. Aqueous Humor Liquid Biopsy to Exclude Retinoblastoma for a Child with an Intraocular Mass. Case reports in ophthalmology. 2025;16:366-371. PMID 40469936 — tags: [clinical-presentation-and-diagnosis] — cited by: clinical-presentation-and-diagnosis.md
• Delhiwala KS, et al. Retinoblastoma: An update. Seminars in diagnostic pathology. 2016;33:133-40. PMID 26969537 — tags: [clinical-presentation-and-diagnosis, genetic-testing-and-counselling, global-access-and-outcome-disparity, rb1-genetics-and-heritability, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, genetic-testing-and-counselling.md, global-access-and-outcome-disparity.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md
• Ramos-Dávila EM, et al. Managing retinoblastoma in 2025. Current opinion in ophthalmology. 2025;36:414-426. PMID 40471757 — tags: [clinical-presentation-and-diagnosis, global-access-and-outcome-disparity, red-flags-and-safety-concerns, systemic-chemotherapy] — cited by: clinical-presentation-and-diagnosis.md, global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md, systemic-chemotherapy.md
• Panda BB, et al. Orbital myiasis in neglected orbital retinoblastoma. The National medical journal of India. 2025;38:353-354. PMID 41645972 — tags: [clinical-presentation-and-diagnosis, global-access-and-outcome-disparity, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md
• Lomi N, et al. Retinoblastoma in Dandy-Walker Syndrome. Cureus. 2025;17:e89663. PMID 40926918 — tags: [clinical-presentation-and-diagnosis, global-access-and-outcome-disparity, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md
• Meel R, et al. Management of Intraocular Retinoblastoma: ICMR Consensus Guidelines. Indian journal of pediatrics. 2024;91:1166-1176. PMID 38609685 — tags: [clinical-presentation-and-diagnosis, global-access-and-outcome-disparity, guidelines, red-flags-and-safety-concerns, systemic-chemotherapy] — cited by: clinical-presentation-and-diagnosis.md, global-access-and-outcome-disparity.md, guidelines.md, red-flags-and-safety-concerns.md, systemic-chemotherapy.md
• Delsin LEA, et al. Expression profiles and prognostic value of miRNAs in retinoblastoma. Journal of cancer research and clinical oncology. 2019;145:1-10. PMID 30350021 — tags: [clinical-presentation-and-diagnosis, global-access-and-outcome-disparity, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md
• Wang N, et al. Retinoblastoma management in China: clinical challenges. International journal of ophthalmology. 2025;18:2380-2384. PMID 41280625 — tags: [clinical-presentation-and-diagnosis, global-access-and-outcome-disparity, red-flags-and-safety-concerns, vision-outcomes-and-patient-experience] — cited by: clinical-presentation-and-diagnosis.md, global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md, vision-outcomes-and-patient-experience.md
• Zhao J, et al. Natural History of Untreated Retinoblastoma. Cancers. 2021;13. PMID 34359552 — tags: [clinical-presentation-and-diagnosis, global-access-and-outcome-disparity, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md
• Yousef YA, et al. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. Journal of pediatric hematology/oncology. 2021;43:e841-e847. PMID 33769386 — tags: [classification-and-staging, overview] — cited by: classification-and-staging.md, overview.md
• Chawla B, et al. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study. Ophthalmology. 2016;123:1933-9. PMID 27449712 — tags: [classification-and-staging, extraocular-metastatic-and-trilateral-disease, systemic-chemotherapy] — cited by: classification-and-staging.md, extraocular-metastatic-and-trilateral-disease.md, systemic-chemotherapy.md
• Kurian DE, et al. High-Risk Retinoblastoma Based on International Classification Systems: Analysis of 1362 Eyes. Ophthalmology. Retina. 2025;9:787-797. PMID 39922380 — tags: [classification-and-staging, enucleation-and-high-risk-pathology, guidelines, intra-arterial-chemotherapy] — cited by: classification-and-staging.md, enucleation-and-high-risk-pathology.md, guidelines.md, intra-arterial-chemotherapy.md
• Scelfo C, et al. An international survey of classification and treatment choices for group D retinoblastoma. International journal of ophthalmology. 2017;10:961-967. PMID 28730089 — tags: [classification-and-staging, intra-arterial-chemotherapy] — cited by: classification-and-staging.md, intra-arterial-chemotherapy.md
• Singh A, et al. Evolving criteria for group E retinoblastoma: impact on outcomes. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024;59:e534-e541. PMID 38830602 — tags: [classification-and-staging, guidelines, intra-arterial-chemotherapy] — cited by: classification-and-staging.md, guidelines.md, intra-arterial-chemotherapy.md
• He X, et al. Effect of intra-arterial chemotherapy drug regimens on globe salvage outcomes of retinoblastoma patients. The British journal of ophthalmology. 2025;109:888-893. PMID 39955086 — tags: [classification-and-staging, intra-arterial-chemotherapy] — cited by: classification-and-staging.md, intra-arterial-chemotherapy.md
• Das A, et al. Intra-arterial Chemotherapy for Retinoblastoma: Real-world Experience. International ophthalmology clinics. 2025;65:60-67. PMID 40993900 — tags: [classification-and-staging, intra-arterial-chemotherapy] — cited by: classification-and-staging.md, intra-arterial-chemotherapy.md
• Jakati S, et al. Aqueous Seeding in Retinoblastoma: Classification and Clinicopathologic Correlation. Ophthalmology. Retina. 2022;6:421-428. PMID 34958963 — tags: [classification-and-staging, intra-arterial-chemotherapy, intravitreal-and-intracameral-chemotherapy] — cited by: classification-and-staging.md, intra-arterial-chemotherapy.md, intravitreal-and-intracameral-chemotherapy.md
• Sedaghat A, et al. Advanced intraocular retinoblastoma: evolving criteria for group E disease. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024;59:e635-e641. PMID 38688458 — tags: [classification-and-staging, intra-arterial-chemotherapy] — cited by: classification-and-staging.md, intra-arterial-chemotherapy.md
• Woldeyohannes AM, et al. Retinoblastoma in Ethiopian Children: Imaging Findings and Staging. Ethiopian journal of health sciences. 2024;34:39-46. PMID 39735524 — tags: [classification-and-staging, extraocular-metastatic-and-trilateral-disease, intra-arterial-chemotherapy] — cited by: classification-and-staging.md, extraocular-metastatic-and-trilateral-disease.md, intra-arterial-chemotherapy.md
• Zafar SN, et al. Tumor Regression Patterns in Retinoblastoma. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 2016;26:896-899. PMID 27981923 — tags: [classification-and-staging, intra-arterial-chemotherapy] — cited by: classification-and-staging.md, intra-arterial-chemotherapy.md
• Vasalaki M, et al. Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma. British medical bulletin. 2017;121:107-119. PMID 28069617 — tags: [classification-and-staging, second-cancers-and-survivorship] — cited by: classification-and-staging.md, second-cancers-and-survivorship.md
• Mengjiang R, et al. [Metachronous bilateral retinoblastoma: a case report]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology. 2024;60:776-778. PMID 39267557 — tags: [classification-and-staging] — cited by: classification-and-staging.md
• AlShimali R, et al. Retinoblastoma presenting as congenital glaucoma. BMJ case reports. 2026;19. PMID 42486661 — tags: [classification-and-staging] — cited by: classification-and-staging.md
• Hussain AK, et al. Globe salvage treatment in group D and group E retinoblastoma. Romanian journal of ophthalmology. 2021;65:20-24. PMID 33817429 — tags: [classification-and-staging] — cited by: classification-and-staging.md
• Fabian ID, et al. Strabismus in retinoblastoma survivors with long-term follow-up. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2018;22:276.e1-276.e7. PMID 30009948 — tags: [classification-and-staging, vision-outcomes-and-patient-experience] — cited by: classification-and-staging.md, vision-outcomes-and-patient-experience.md
• Yousef YA, et al. Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020). Ophthalmic genetics. 2023;44:119-126. PMID 35848346 — tags: [classification-and-staging] — cited by: classification-and-staging.md
• Kaliki S. Aqueous seeding in intraocular retinoblastoma: A review. Clinical & experimental ophthalmology. 2021;49:606-614. PMID 34185374 — tags: [classification-and-staging] — cited by: classification-and-staging.md
• Fabian ID, et al. Classification and staging of retinoblastoma. Community eye health. 2018;31:11-13. PMID 29915461 — tags: [classification-and-staging, guidelines] — cited by: classification-and-staging.md, guidelines.md
• Metz KA, et al. [Retinoblastoma and retinocytoma (retinoma)]. Der Pathologe. 2017;38:507-514. PMID 29043448 — tags: [classification-and-staging, enucleation-and-high-risk-pathology, extraocular-metastatic-and-trilateral-disease] — cited by: classification-and-staging.md, enucleation-and-high-risk-pathology.md, extraocular-metastatic-and-trilateral-disease.md
• Tomar AS, et al. Diffuse infiltrating retinoblastoma: a multicentre, international, data-sharing study. The British journal of ophthalmology. 2025;109:1409-1416. PMID 40738737 — tags: [classification-and-staging, systemic-chemotherapy] — cited by: classification-and-staging.md, systemic-chemotherapy.md
• Grabowski EF, et al. Intraocular and extraocular retinoblastoma. Hematology/oncology clinics of North America. 1987;1:721-35. PMID 3323180 — tags: [classification-and-staging, extraocular-metastatic-and-trilateral-disease, genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: classification-and-staging.md, extraocular-metastatic-and-trilateral-disease.md, genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Barkhof F, et al. MR imaging in retinoblastoma. European radiology. 1997;7:726-31. PMID 9166573 — tags: [classification-and-staging, clinical-presentation-and-diagnosis] — cited by: classification-and-staging.md, clinical-presentation-and-diagnosis.md
• Leal-Leal CA, et al. Survival in extra-orbital metastatic retinoblastoma:treatment results. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2006;8:39-44. PMID 16632438 — tags: [classification-and-staging, extraocular-metastatic-and-trilateral-disease] — cited by: classification-and-staging.md, extraocular-metastatic-and-trilateral-disease.md
• Zhao J, et al. Retinoblastoma Survival Following Primary Enucleation by AJCC Staging. Cancers. 2021;13. PMID 34944860 — tags: [classification-and-staging] — cited by: classification-and-staging.md
• Soliman SE, et al. Genetics and Molecular Diagnostics in Retinoblastoma--An Update. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2017;6:197-207. PMID 28399338 — tags: [classification-and-staging] — cited by: classification-and-staging.md
• Bakhshi S, et al. Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging. Journal of pediatric hematology/oncology. 2011;33:e182-5. PMID 21364467 — tags: [classification-and-staging, extraocular-metastatic-and-trilateral-disease] — cited by: classification-and-staging.md, extraocular-metastatic-and-trilateral-disease.md
• Yanagihara RT, et al. Clinical Stage of Retinoblastoma Based on Presenting Signs of 4578 Patients from 121 Countries. Ophthalmology. 2025;132:1045-1053. PMID 40334716 — tags: [classification-and-staging, clinical-presentation-and-diagnosis, extraocular-metastatic-and-trilateral-disease] — cited by: classification-and-staging.md, clinical-presentation-and-diagnosis.md, extraocular-metastatic-and-trilateral-disease.md
• Radhakrishnan V, et al. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study. Ophthalmology. 2012;119:1470-7. PMID 22463820 — tags: [classification-and-staging, extraocular-metastatic-and-trilateral-disease] — cited by: classification-and-staging.md, extraocular-metastatic-and-trilateral-disease.md
• Yu CL, et al. Cause-specific mortality in long-term survivors of retinoblastoma. Journal of the National Cancer Institute. 2009;101:581-91. PMID 19351917 — tags: [second-cancers-and-survivorship] — cited by: second-cancers-and-survivorship.md
• Kleinerman RA, et al. Bone and Soft-Tissue Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Treated With Radiation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019;37:3436-3445. PMID 31622129 — tags: [red-flags-and-safety-concerns, second-cancers-and-survivorship] — cited by: red-flags-and-safety-concerns.md, second-cancers-and-survivorship.md
• Jullien S. Vision screening in newborns and early childhood. BMC pediatrics. 2021;21:306. PMID 34496780 — tags: [clinical-presentation-and-diagnosis] — cited by: clinical-presentation-and-diagnosis.md

Genetics and molecular pathogenesis

• Li WL, et al. A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families. The Journal of molecular diagnostics : JMD. 2016;18:480-93. PMID 27155049 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Lohmann DR, et al. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. American journal of human genetics. 1997;61:282-94. PMID 9311732 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Lohmann D. Retinoblastoma. Advances in experimental medicine and biology. 2010;685:220-7. PMID 20687510 — tags: [genetic-testing-and-counselling, molecular-pathogenesis-and-cell-of-origin, rb1-genetics-and-heritability, second-cancers-and-survivorship] — cited by: genetic-testing-and-counselling.md, molecular-pathogenesis-and-cell-of-origin.md, rb1-genetics-and-heritability.md, second-cancers-and-survivorship.md
• Mallipatna A, et al. Genetics of Retinoblastoma. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2016;5:260-4. PMID 27488068 — tags: [genetic-testing-and-counselling, molecular-pathogenesis-and-cell-of-origin, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, molecular-pathogenesis-and-cell-of-origin.md, rb1-genetics-and-heritability.md
• Tu J, et al. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies. Proceedings of the National Academy of Sciences of the United States of America. 2022;119:e2117857119. PMID 35412907 — tags: [genetic-testing-and-counselling, global-access-and-outcome-disparity, molecular-pathogenesis-and-cell-of-origin, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, global-access-and-outcome-disparity.md, molecular-pathogenesis-and-cell-of-origin.md, rb1-genetics-and-heritability.md
• Kamihara J, et al. Retinoblastoma and Neuroblastoma Predisposition and Surveillance. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017;23:e98-e106. PMID 28674118 — tags: [genetic-testing-and-counselling, guidelines, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, guidelines.md, rb1-genetics-and-heritability.md
• Lindquist M, et al. Retinoblastoma: Advances in Genetic Testing. International ophthalmology clinics. 2025;65:42-46. PMID 40993897 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Chévez-Barrios P, et al. DNA Assays to Detect and Characterize RB1 Mosaicism in Retinoblastoma. JAMA ophthalmology. 2025;143:568-569. PMID 40338597 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Gao C, et al. Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test. JAMA ophthalmology. 2025;143:562-568. PMID 40338593 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Chantada GL, et al. Challenges for Early Diagnosis in Retinoblastoma in Low- and Middle-Income Countries. Pediatric blood & cancer. 2025;72:e31859. PMID 40619694 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Dehainault C, et al. Mosaicism and prenatal diagnosis options: insights from retinoblastoma. European journal of human genetics : EJHG. 2017;25:381-383. PMID 28000698 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Gupta H, et al. Retinoblastoma genetics screening and clinical management. BMC medical genomics. 2021;14:188. PMID 34294096 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Schweiger B, et al. [Imaging of retinoblastoma : Current state-of-the-art and future prospects]. Radiologie (Heidelberg, Germany). 2022;62:1067-1074. PMID 35969246 — tags: [clinical-presentation-and-diagnosis, genetic-testing-and-counselling, rb1-genetics-and-heritability, red-flags-and-safety-concerns] — cited by: clinical-presentation-and-diagnosis.md, genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md, red-flags-and-safety-concerns.md
• Margo CE, et al. Retinoblastoma. Cancer control : journal of the Moffitt Cancer Center. 1998;5:310-316. PMID 10761080 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability, second-cancers-and-survivorship] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md, second-cancers-and-survivorship.md
• Nag A, et al. Genetics of Retinoblastoma - An Update. Seminars in ophthalmology. 2025;40:609-617. PMID 40235228 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Bouchoucha Y, et al. Retinoblastoma: From genes to patient care. European journal of medical genetics. 2023;66:104674. PMID 36470558 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Marković L, et al. Genetics in ophthalmology: molecular blueprints of retinoblastoma. Human genomics. 2023;17:82. PMID 37658463 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Abu-Amero KK, et al. Genetics of Retinoblastoma: An Overview and Significance of Genetic Testing in Clinical Practice. Genes. 2025;16. PMID 41009976 — tags: [genetic-testing-and-counselling, rb1-genetics-and-heritability] — cited by: genetic-testing-and-counselling.md, rb1-genetics-and-heritability.md
• Kamihara J, et al. Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025;31:1573-1579. PMID 39998650 — tags: [genetic-testing-and-counselling, guidelines] — cited by: genetic-testing-and-counselling.md, guidelines.md
• Tonorezos ES, et al. Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma. Ophthalmology. 2020;127:1549-1557. PMID 32422154 — tags: [genetic-testing-and-counselling, guidelines, second-cancers-and-survivorship] — cited by: genetic-testing-and-counselling.md, guidelines.md, second-cancers-and-survivorship.md
• Yang J, et al. Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma. Cell death & disease. 2021;12:1100. PMID 34815392 — tags: [molecular-pathogenesis-and-cell-of-origin] — cited by: molecular-pathogenesis-and-cell-of-origin.md
• Liu J, et al. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nature communications. 2021;12:5578. PMID 34552068 — tags: [molecular-pathogenesis-and-cell-of-origin] — cited by: molecular-pathogenesis-and-cell-of-origin.md
• Zugbi S, et al. Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers. 2020;12. PMID 32971811 — tags: [molecular-pathogenesis-and-cell-of-origin] — cited by: molecular-pathogenesis-and-cell-of-origin.md
• Zhang X, et al. Reconstruct Human Retinoblastoma In Vitro. Journal of visualized experiments : JoVE. 2022. PMID 36314812 — tags: [molecular-pathogenesis-and-cell-of-origin] — cited by: molecular-pathogenesis-and-cell-of-origin.md
• Yang J, et al. Diffuse anterior retinoblastoma: current concepts. OncoTargets and therapy. 2015;8:1815-21. PMID 26229489 — tags: [molecular-pathogenesis-and-cell-of-origin] — cited by: molecular-pathogenesis-and-cell-of-origin.md
• Li YP, et al. Second hit impels oncogenesis of retinoblastoma in patient-induced pluripotent stem cell-derived retinal organoids: direct evidence for Knudson's theory. PNAS nexus. 2022;1:pgac162. PMID 36714839 — tags: [molecular-pathogenesis-and-cell-of-origin] — cited by: molecular-pathogenesis-and-cell-of-origin.md
• De Rosa P, et al. MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma Cells. International journal of molecular sciences. 2023;24. PMID 36982482 — tags: [molecular-pathogenesis-and-cell-of-origin] — cited by: molecular-pathogenesis-and-cell-of-origin.md
• Xu L, et al. Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival. Molecular cancer research : MCR. 2020;18:1166-1175. PMID 32434859 — tags: [clinical-trials-landscape, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: clinical-trials-landscape.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Li HT, et al. Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy. Nature communications. 2022;13:5523. PMID 36130950 — tags: [clinical-trials-landscape, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: clinical-trials-landscape.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Ghose N, et al. Liquid biopsy in Retinoblastoma: A review. Seminars in ophthalmology. 2022;37:813-819. PMID 35604935 — tags: [clinical-trials-landscape, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: clinical-trials-landscape.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Sirivolu S, et al. Single-cell somatic copy number alteration profiling of vitreous humor seeds in retinoblastoma. Ophthalmic genetics. 2024;45:646-649. PMID 39016001 — tags: [clinical-trials-landscape, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: clinical-trials-landscape.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Meel R, et al. Tumor DNA sampling from aqueous humor in retinoblastoma - A report from South Asia. Indian journal of ophthalmology. 2024;72:1012-1016. PMID 38454873 — tags: [clinical-trials-landscape, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: clinical-trials-landscape.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Amacker A, et al. Phenotypic Biomarkers of Aqueous Extracellular Vesicles from Retinoblastoma Eyes. International journal of molecular sciences. 2024;25. PMID 39519212 — tags: [clinical-trials-landscape, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: clinical-trials-landscape.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Cuadrado-Vilanova M, et al. Follow-up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients. The journal of pathology. Clinical research. 2023;9:32-43. PMID 36148636 — tags: [clinical-trials-landscape, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: clinical-trials-landscape.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Raval V, et al. Aqueous humor as a surrogate biomarker for retinoblastoma tumor tissue. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2022;26:137.e1-137.e5. PMID 35577019 — tags: [clinical-trials-landscape, intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: clinical-trials-landscape.md, intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Berry JL, et al. Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma. JAMA ophthalmology. 2017;135:1221-1230. PMID 29049475 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Le Gall J, et al. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. The Journal of molecular diagnostics : JMD. 2021;23:1714-1721. PMID 34656762 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Pike S, et al. CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma Associated. Investigative ophthalmology & visual science. 2023;64:5. PMID 37410475 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Kim ME, et al. Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma. Cancers. 2021;13. PMID 34283049 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Berry JL, et al. Aqueous Humor Liquid Biopsy as a Companion Diagnostic for Retinoblastoma: Implications for Diagnosis, Prognosis, and Therapeutic Options: Five Years of Progress. American journal of ophthalmology. 2024;263:188-205. PMID 38040321 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Mendes TB, et al. Retinoblastoma: Molecular Evaluation of Tumor Samples, Aqueous Humor, and Peripheral Blood Using a Next-Generation Sequence Panel. International journal of molecular sciences. 2025;26. PMID 40332023 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Zamani Sani M, et al. MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little Heroes. Biochemical genetics. 2025;63:1176-1197. PMID 39862293 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Darajati IT, et al. The utility of aqueous humor liquid biopsy in retinoblastoma genetic analysis: a systematic review of concordance and influencing factors. Ophthalmic genetics. 2026;47:227-237. PMID 41521223 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Xu L, et al. Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes. Ophthalmic genetics. 2020;41:526-532. PMID 32799607 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Berry JL, et al. The RB1 Story: Characterization and Cloning of the First Tumor Suppressor Gene. Genes. 2019;10. PMID 31683923 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Berry JL, et al. Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma. Molecular cancer research : MCR. 2018;16:1701-1712. PMID 30061186 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Xu L, et al. Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers. 2021;13. PMID 33805776 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Darajati IT, et al. A bird's eye view on potential molecular prognostic markers in retinoblastoma: insights for precision oncology. Ophthalmic genetics. 2026;47:125-136. PMID 41542805 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Zeng Q, et al. The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study. PeerJ. 2021;9:e10830. PMID 33717678 — tags: [intravitreal-and-intracameral-chemotherapy, molecular-pathogenesis-and-cell-of-origin] — cited by: intravitreal-and-intracameral-chemotherapy.md, molecular-pathogenesis-and-cell-of-origin.md
• Yang H, et al. Abemaciclib Inhibits Retinoblastoma Tumor Growth by Targeting CDK1/2. Investigative ophthalmology & visual science. 2026;67:72. PMID 42212883 — tags: [molecular-pathogenesis-and-cell-of-origin] — cited by: molecular-pathogenesis-and-cell-of-origin.md

Local and systemic treatment

• Ye H, et al. Three vs 6 Cycles of Chemotherapy for High-Risk Retinoblastoma: A Randomized Clinical Trial. JAMA. 2024;332:1634-1641. PMID 39432296 — tags: [clinical-trials-landscape, enucleation-and-high-risk-pathology, overview, systemic-chemotherapy, vision-outcomes-and-patient-experience] — cited by: clinical-trials-landscape.md, enucleation-and-high-risk-pathology.md, overview.md, systemic-chemotherapy.md, vision-outcomes-and-patient-experience.md
• Shields JA, et al. Chemoreduction in the management of retinoblastoma. American journal of ophthalmology. 2005;140:505-6. PMID 16139001 — tags: [focal-therapy-and-brachytherapy, systemic-chemotherapy] — cited by: focal-therapy-and-brachytherapy.md, systemic-chemotherapy.md
• Zhang X, et al. Prospects of anti-GD2 immunotherapy for retinoblastoma. Frontiers in immunology. 2024;15:1499700. PMID 39620227 — tags: [focal-therapy-and-brachytherapy, systemic-chemotherapy, vision-outcomes-and-patient-experience] — cited by: focal-therapy-and-brachytherapy.md, systemic-chemotherapy.md, vision-outcomes-and-patient-experience.md
• Shields CL, et al. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Current opinion in ophthalmology. 2010;21:203-12. PMID 20224400 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Santapuram PR, et al. Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma. Ophthalmology. Retina. 2021;5:309-312. PMID 32920208 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Raval V, et al. Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2020;10:200-202. PMID 32925294 — tags: [intravitreal-and-intracameral-chemotherapy, systemic-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md, systemic-chemotherapy.md
• Shields CL, et al. Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (London, England). 2013;27:253-64. PMID 22995941 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Mendoza PR, et al. Therapeutic Options for Retinoblastoma. Cancer control : journal of the Moffitt Cancer Center. 2016;23:99-109. PMID 27218786 — tags: [focal-therapy-and-brachytherapy, systemic-chemotherapy] — cited by: focal-therapy-and-brachytherapy.md, systemic-chemotherapy.md
• Yanık Ö, et al. Chemotherapy in Retinoblastoma: Current Approaches. Turkish journal of ophthalmology. 2015;45:259-267. PMID 27800245 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Shields CL, et al. Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned? Current opinion in ophthalmology. 2012;23:202-9. PMID 22450222 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Shields CL, et al. Chemoreduction for retinoblastoma may prevent trilateral retinoblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000;18:236-7. PMID 10623718 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Raval V, et al. Management of retinoblastoma: are we there yet? Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024;59:376-379. PMID 38431272 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Kumari N, et al. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma. Indian journal of ophthalmology. 2023;71:436-443. PMID 36727336 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Global Retinoblastoma Study Group. Global retinoblastoma service availability in 2024 and equity trends since 2017. The British journal of ophthalmology. 2026. PMID 42463304 — tags: [global-access-and-outcome-disparity, systemic-chemotherapy] — cited by: global-access-and-outcome-disparity.md, systemic-chemotherapy.md
• Kritfuangfoo T, et al. Update on chemotherapy modalities for retinoblastoma: Progress and challenges. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2024;13:100061. PMID 38641204 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Demirci H, et al. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Archives of ophthalmology (Chicago, Ill. : 1960). 2003;121:1125-31. PMID 12912690 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Schaiquevich P, et al. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma. Pediatric blood & cancer. 2013;60:766-70. PMID 23024125 — tags: [systemic-chemotherapy] — cited by: systemic-chemotherapy.md
• Chintagumpala M, et al. A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1). Pediatric blood & cancer. 2024;71:e30718. PMID 37817345 — tags: [clinical-trials-landscape, intra-arterial-chemotherapy, red-flags-and-safety-concerns, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, intra-arterial-chemotherapy.md, red-flags-and-safety-concerns.md, systemic-chemotherapy.md
• Jubran RF, et al. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231). Pediatric blood & cancer. 2020;67:e28502. PMID 32589362 — tags: [clinical-trials-landscape, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, systemic-chemotherapy.md
• Wen X, et al. Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial. The Lancet. Child & adolescent health. 2023;7:613-620. PMID 37536351 — tags: [clinical-trials-landscape, intra-arterial-chemotherapy, overview, red-flags-and-safety-concerns, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, intra-arterial-chemotherapy.md, overview.md, red-flags-and-safety-concerns.md, systemic-chemotherapy.md
• Zeng C, et al. Hemostatic effect of 3D-printed hip fixators in children with retinoblastoma after intra-arterial chemotherapy: a non-randomized controlled trial. Scientific reports. 2024;14:27613. PMID 39528689 — tags: [clinical-trials-landscape, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, systemic-chemotherapy.md
• Chen Q, et al. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis. BMC cancer. 2018;18:486. PMID 29703164 — tags: [clinical-trials-landscape, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, systemic-chemotherapy.md
• Weinberger Y, et al. Intra-arterial chemotherapy for retinoblastoma: a performance analysis. The British journal of ophthalmology. 2025;109:1298-1305. PMID 40541288 — tags: [clinical-trials-landscape, intra-arterial-chemotherapy, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, intra-arterial-chemotherapy.md, systemic-chemotherapy.md
• Diarra Y, et al. Adjuvant therapy for children treated by enucleation at diagnosis of retinoblastoma. EJC paediatric oncology. 2023;1:None. PMID 40061040 — tags: [clinical-trials-landscape, enucleation-and-high-risk-pathology, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, enucleation-and-high-risk-pathology.md, systemic-chemotherapy.md
• Zhao J, et al. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma. Ophthalmology. Retina. 2020;4:630-639. PMID 32387053 — tags: [clinical-trials-landscape, red-flags-and-safety-concerns, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, red-flags-and-safety-concerns.md, systemic-chemotherapy.md
• Grümme L, et al. Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma. Pediatric blood & cancer. 2022;69:e29362. PMID 34606174 — tags: [clinical-trials-landscape, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, systemic-chemotherapy.md
• Shields CL, et al. Practical approach to management of retinoblastoma. Archives of ophthalmology (Chicago, Ill. : 1960). 2004;122:729-35. PMID 15136321 — tags: [clinical-trials-landscape, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, systemic-chemotherapy.md
• Shields CL, et al. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma. Ophthalmology. 2014;121:1453-60. PMID 24656794 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Abramson DH, et al. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma. PloS one. 2016;11:e0146582. PMID 26756643 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Rowlands MA, et al. Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery. PloS one. 2018;13:e0195395. PMID 29698399 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Zanaty M, et al. Update on intra-arterial chemotherapy for retinoblastoma. TheScientificWorldJournal. 2014;2014:869604. PMID 25405236 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Runnels J, et al. The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2021;23:2066-2077. PMID 33826082 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Khaqan HA, et al. Experience of selective intra-arterial chemotherapy for Retinoblastoma. JPMA. The Journal of the Pakistan Medical Association. 2020;70:178-182. PMID 31954049 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Alshahrani NO, et al. Single- Versus Triple-Agent Intra-Arterial Chemotherapy for Retinoblastoma. American journal of ophthalmology. 2025;269:488-496. PMID 39395595 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Yousef YA, et al. Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors. Cancers. 2025;17. PMID 40563605 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Wang L, et al. Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: Results and short-term complications. Medicine. 2018;97:e12676. PMID 30334950 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Ren YH, et al. Intra-arterial chemotherapy for retinoblastoma: a structured narrative review. World journal of pediatric surgery. 2026;9:e001213. PMID 42553724 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Jubran JH, et al. Efficacy of a prolonged stability melphalan formulation for intra-arterial treatment of retinoblastoma. Journal of neurointerventional surgery. 2024;16:572-577. PMID 37380354 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Stenzel E, et al. Feasibility of intra-arterial chemotherapy for retinoblastoma: experiences in a large single center cohort study. Neuroradiology. 2019;61:351-357. PMID 30643921 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Abramson DH, et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117:1623-9. PMID 20381868 — tags: [clinical-trials-landscape, intra-arterial-chemotherapy] — cited by: clinical-trials-landscape.md, intra-arterial-chemotherapy.md
• Chen M, et al. Outcome of intra-arterial chemotherapy for retinoblastoma and its influencing factors: a retrospective study. Acta ophthalmologica. 2017;95:613-618. PMID 27874261 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Parareda A, et al. Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study. Acta ophthalmologica. 2014;92:209-15. PMID 24868582 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Muen WJ, et al. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma. Ophthalmology. 2012;119:611-6. PMID 22197434 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Gobin YP, et al. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Archives of ophthalmology (Chicago, Ill. : 1960). 2011;129:732-7. PMID 21320950 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Rishi P, et al. Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India. Indian journal of ophthalmology. 2017;65:311-315. PMID 28513496 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Teixeira LF, et al. Intra-arterial Chemotherapy for Retinoblastoma, Outcomes Analysis in 357 Eyes: Thirteen Years of Experience in a Referral Center in Brazil. Ophthalmology. Retina. 2025;9:798-806. PMID 39971005 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Rishi P, et al. Intra-arterial chemotherapy for retinoblastoma: First Indian report. Indian journal of ophthalmology. 2015;63:331-4. PMID 26044473 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Reddy MA, et al. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma. The British journal of ophthalmology. 2017;101:1704-1708. PMID 28432112 — tags: [intra-arterial-chemotherapy, red-flags-and-safety-concerns] — cited by: intra-arterial-chemotherapy.md, red-flags-and-safety-concerns.md
• Das A, et al. Outcomes and adverse events following intra-arterial chemotherapy for retinoblastoma: A single center study in South India. World journal of clinical pediatrics. 2025;14:103732. PMID 40881098 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Hua J, et al. Intra-arterial chemotherapy as second-line treatment for advanced retinoblastoma: A 2-year single-center study in China. Journal of cancer research and therapeutics. 2018;14:106-110. PMID 29516970 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Rokohl AC, et al. Intravenous chemotherapy versus intra-arterial chemotherapy for retinoblastoma. The Cochrane database of systematic reviews. 2026;2:CD013695. PMID 41700592 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Bravo-Gonzalez A, et al. The Role of Intravitreal Chemotherapy as an Adjunctive Treatment for Retinoblastoma: A Systematic Review and Single-Arm Meta-Analysis. American journal of ophthalmology. 2025;273:130-140. PMID 39701510 — tags: [intra-arterial-chemotherapy] — cited by: intra-arterial-chemotherapy.md
• Munier FL, et al. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track. The British journal of ophthalmology. 2012;96:1084-7. PMID 22368262 — tags: [intravitreal-and-intracameral-chemotherapy, red-flags-and-safety-concerns] — cited by: intravitreal-and-intracameral-chemotherapy.md, red-flags-and-safety-concerns.md
• Shields CL, et al. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture. Retina (Philadelphia, Pa.). 2016;36:1184-90. PMID 26630319 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• Yousef YA, et al. Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma. Frontiers in pharmacology. 2021;12:696787. PMID 34322023 — tags: [intravitreal-and-intracameral-chemotherapy, red-flags-and-safety-concerns] — cited by: intravitreal-and-intracameral-chemotherapy.md, red-flags-and-safety-concerns.md
• Munier FL, et al. Intracameral Chemotherapy (Melphalan) for Aqueous Seeding in Retinoblastoma: Bicameral Injection Technique and Related Toxicity in a Pilot Case Study. Ocular oncology and pathology. 2017;3:149-155. PMID 28868287 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• Solana-Altabella A, et al. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2020;26:1829-1835. PMID 32063104 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• Agarwal A, et al. Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma: A Comparative Study of 64 Asian Indian Eyes. Ophthalmology. Retina. 2025;9:589-597. PMID 39566884 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• Amin S, et al. Outcomes of Group D Retinoblastoma With Resistant Vitreous Seeds After Integration of Intravitreal Chemotherapy to the Treatment Protocol. Cureus. 2020;12:e11757. PMID 33409006 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• Said AMA, et al. Safety and efficacy of posterior sub-Tenon's carboplatin injection versus intravitreal melphalan therapy in the management of retinoblastoma with secondary vitreous seeds. International journal of ophthalmology. 2018;11:445-455. PMID 29600179 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• Agarwal A, et al. Intravitreal Chemotherapy in Retinoblastoma: Current Trends and Future Directions. International ophthalmology clinics. 2025;65:68-73. PMID 40993901 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• King BA, et al. Intravitreal Carboplatin as Salvage Treatment for Progressive Vitreous Disease in Retinoblastoma: A Phase I Clinical Trial. Ophthalmology. Retina. 2023;7:354-359. PMID 36372348 — tags: [clinical-trials-landscape, intravitreal-and-intracameral-chemotherapy, red-flags-and-safety-concerns] — cited by: clinical-trials-landscape.md, intravitreal-and-intracameral-chemotherapy.md, red-flags-and-safety-concerns.md
• Lin XT, et al. [The efficacy of topotecan versus topotecan combined with melphalan in the treatment of vitreous seeds in retinoblastoma]. [Zhonghua yan ke za zhi] Chinese journal of ophthalmology. 2025;61:871-878. PMID 41218901 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• Mohney BG, et al. Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma. Ophthalmic surgery, lasers & imaging retina. 2017;48:151-159. PMID 28195618 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• Sen M, et al. Intraocular seeds in retinoblastoma: A review of classification, management, and outcomes. Survey of ophthalmology. 2026;71:361-381. PMID 40819690 — tags: [intravitreal-and-intracameral-chemotherapy] — cited by: intravitreal-and-intracameral-chemotherapy.md
• Shields JA, et al. Cryotherapy for retinoblastoma. International ophthalmology clinics. 1993;33:101-5. PMID 8407173 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Chan HS, et al. Chemotherapy for retinoblastoma. Ophthalmology clinics of North America. 2005;18:55-63, viii. PMID 15763191 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Carnevale JA, et al. Intra-arterial chemotherapy for retinoblastoma. Journal of neurointerventional surgery. 2023;15:303-304. PMID 35584909 — tags: [focal-therapy-and-brachytherapy, global-access-and-outcome-disparity] — cited by: focal-therapy-and-brachytherapy.md, global-access-and-outcome-disparity.md
• Chawla B, et al. Recent advances and challenges in the management of retinoblastoma. Indian journal of ophthalmology. 2017;65:133-139. PMID 28345569 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Chandra K, et al. Primary Macular Retinoblastoma: Clinical Presentation and Treatment Outcomes. Journal of vitreoretinal diseases. 2022;6:367-373. PMID 37006899 — tags: [focal-therapy-and-brachytherapy, vision-outcomes-and-patient-experience] — cited by: focal-therapy-and-brachytherapy.md, vision-outcomes-and-patient-experience.md
• Lin P, et al. Frontiers in the management of retinoblastoma. American journal of ophthalmology. 2009;148:192-8. PMID 19477707 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Shields CL, et al. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Current opinion in ophthalmology. 2014;25:374-85. PMID 25014750 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Elaraoud I, et al. Management of retinal detachment in retinoblastoma with globe conserving treatment. Journal of current ophthalmology. 2019;31:43-48. PMID 30899845 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Atchaneeyasakul LO, et al. Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study. Japanese journal of ophthalmology. 2009;53:35-39. PMID 19184307 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Temming P, et al. [Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision]. Klinische Monatsblatter fur Augenheilkunde. 2013;230:232-42. PMID 23508752 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Shields CL, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology. 1997;104:2101-11. PMID 9400771 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Zage PE, et al. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Pediatric blood & cancer. 2008;50:567-72. PMID 17729249 — tags: [clinical-trials-landscape, focal-therapy-and-brachytherapy] — cited by: clinical-trials-landscape.md, focal-therapy-and-brachytherapy.md
• Lumbroso-Le Rouic L, et al. Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study. Ophthalmology. Retina. 2021;5:e30-e37. PMID 34000459 — tags: [clinical-trials-landscape, focal-therapy-and-brachytherapy, intra-arterial-chemotherapy] — cited by: clinical-trials-landscape.md, focal-therapy-and-brachytherapy.md, intra-arterial-chemotherapy.md
• Abramson DH, et al. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success. Ophthalmology. 2004;111:984-91. PMID 15121378 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Berman EL, et al. Outcomes in retinoblastoma, 1974-2005: the Children's Hospital, Westmead. Clinical & experimental ophthalmology. 2007;35:5-12. PMID 17300564 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Shields CL, et al. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology. 2001;108:2116-21. PMID 11713089 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Morawski K, et al. [Available approaches to retinoblastoma therapy--literature review]. Klinika oczna. 2015;117:45-9. PMID 26349159 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Murphree AL, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Archives of ophthalmology (Chicago, Ill. : 1960). 1996;114:1348-56. PMID 8906025 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Gündüz K, et al. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Archives of ophthalmology (Chicago, Ill. : 1960). 1998;116:1613-7. PMID 9869790 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Gündüz K, et al. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Ophthalmology. 2004;111:1917-24. PMID 15465557 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Antoneli CB, et al. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. Journal of pediatric hematology/oncology. 2006;28:342-5. PMID 16794500 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Shin JY, et al. Eye-preserving therapy in retinoblastoma: prolonged primary chemotherapy alone or combined with local therapy. Korean journal of ophthalmology : KJO. 2010;24:219-24. PMID 20714385 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Friedman DL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000;18:12-7. PMID 10623688 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Feng ZX, et al. Adjuvant Chemotherapy Improves Survival for Children With Massive Choroidal Invasion of Retinoblastoma. Investigative ophthalmology & visual science. 2023;64:27. PMID 37603354 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Kaliki S, et al. Defining High-risk Retinoblastoma: A Multicenter Global Survey. JAMA ophthalmology. 2022;140:30-36. PMID 34762098 — tags: [enucleation-and-high-risk-pathology, guidelines] — cited by: enucleation-and-high-risk-pathology.md, guidelines.md
• Lin M, et al. Adjuvant Chemotherapy in Retinoblastoma with Postlaminar Optic Nerve Invasion: A Global Multicenter Study. Ophthalmology. Retina. 2026;10:562-572. PMID 41475682 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Sunwoo Y, et al. Twenty-Year Retrospective Study of Post-Enucleation Chemotherapy in High-Risk Patients with Unilateral Retinoblastoma. Children (Basel, Switzerland). 2022;9. PMID 36553426 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Arazi M, et al. Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma. American journal of ophthalmology. 2024;268:399-408. PMID 39332513 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Honavar SG, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Archives of ophthalmology (Chicago, Ill. : 1960). 2002;120:923-31. PMID 12096963 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Kaliki S, et al. HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 Continents. Retina (Philadelphia, Pa.). 2024;44:2105-2115. PMID 39151183 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Chong EM, et al. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Archives of pathology & laboratory medicine. 2006;130:1669-72. PMID 17076529 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Kashyap S, et al. Clinical predictors of high risk histopathology in retinoblastoma. Pediatric blood & cancer. 2012;58:356-61. PMID 21721113 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Mohammad M, et al. A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma. European journal of ophthalmology. 2023;33:2014-2023. PMID 36760120 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Chantada GL, et al. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? The British journal of ophthalmology. 2004;88:1069-73. PMID 15258027 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Mustafa MM, et al. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma. Journal of pediatric hematology/oncology. 1999;21:364-9. PMID 10524448 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Fabian ID, et al. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes. Ophthalmology. 2017;124:851-858. PMID 28302322 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Kaliki S, et al. HIGH-RISK INTRAOCULAR RETINOBLASTOMA: Comparison Between Asian Indians and Americans From Two Major Referral Centers. Retina (Philadelphia, Pa.). 2018;38:2023-2029. PMID 28834944 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Kaliki S, et al. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study. Ophthalmology. 2015;122:1165-72. PMID 25841975 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Künkele A, et al. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre. The British journal of ophthalmology. 2015;99:949-53. PMID 25583279 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Chévez-Barrios P, et al. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019;37:2883-2891. PMID 31539297 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Dittner-Moormann S, et al. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatric blood & cancer. 2021;68:e28963. PMID 33720495 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Luna-Fineman S, et al. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019;37:2875-2882. PMID 31536438 — tags: [enucleation-and-high-risk-pathology, extraocular-metastatic-and-trilateral-disease] — cited by: enucleation-and-high-risk-pathology.md, extraocular-metastatic-and-trilateral-disease.md
• Wang YZ, et al. [Treatment and prognostic analysis of retinoblastoma patients with choroid invasion]. Zhonghua er ke za zhi = Chinese journal of pediatrics. 2016;54:819-822. PMID 27806788 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Kaliki S, et al. Impact of Race on the Outcomes of Retinoblastoma Treated With Primary Enucleation: A Global Study of 1426 Patients. Clinical & experimental ophthalmology. 2025;53:421-434. PMID 39731391 — tags: [enucleation-and-high-risk-pathology, global-access-and-outcome-disparity] — cited by: enucleation-and-high-risk-pathology.md, global-access-and-outcome-disparity.md
• Pendri PR, et al. Controversies in the Management of Choroidal Invasion in Retinoblastoma. International ophthalmology clinics. 2022;62:27-37. PMID 36170219 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Tang J, et al. Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression. Biomarker research. 2024;12:48. PMID 38730450 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Loya A, et al. Association of choroidal invasion with retinoblastoma survival rates. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2023;27:32.e1-32.e8. PMID 36610585 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Apumayta ED, et al. Liver metastasis of retinoblastoma. Ecancermedicalscience. 2025;19:1824. PMID 40177152 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Zhu T, et al. Spatial Proteomic Analysis Highlights Molecular Reprogramming in Optic Nerve Invasive Retinoblastoma. Investigative ophthalmology & visual science. 2025;66:37. PMID 41129126 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Abramson DH, et al. Ophthalmic Artery Chemosurgery for Optic Nerve Invasion in Retinoblastoma. Journal of pediatric ophthalmology and strabismus. 2025;62:150. PMID 38815108 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Abramson DH, et al. Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intra-arterial Chemotherapy (Ophthalmic Artery Chemosurgery). Ophthalmology. Retina. 2021;5:936-939. PMID 33383259 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Yang E, et al. Angiogenesis Signaling in Retinoblastoma: Prognostic and Therapeutic Applications. International ophthalmology clinics. 2025;65:35-41. PMID 40993896 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Thakur S, et al. Multidisciplinary Approach for Retinoblastoma Management. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH. 2021;13:234-236. PMID 35996791 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Kheir WJ, et al. High-risk features in retinoblastoma: the association between histopathology and MRI. BMJ open ophthalmology. 2025;10. PMID 41043969 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Koenig LR, et al. Multimodal Imaging of Optic Nerve Invasion in Unilateral Retinoblastoma. Ophthalmology. 2026. PMID 42397330 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Thaung C, et al. Standard reporting of high-risk histopathology features in retinoblastoma. Community eye health. 2018;31:17. PMID 29915463 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Thaung C, et al. Standard reporting of high-risk histopathology features in retinoblastoma. Community eye health. 2018;31:31-33. PMID 29915470 — tags: [enucleation-and-high-risk-pathology] — cited by: enucleation-and-high-risk-pathology.md
• Lumbroso-Le Rouic L, et al. Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy. Eye (London, England). 2016;30:46-52. PMID 26427984 — tags: [focal-therapy-and-brachytherapy] — cited by: focal-therapy-and-brachytherapy.md
• Roy PS, et al. A single-blinded, randomized controlled trial of standard versus higher dose carboplatin-based intravenous chemotherapy for group D and E retinoblastoma. Pediatric blood & cancer. 2023;70:e30444. PMID 37243382 — tags: [clinical-trials-landscape, systemic-chemotherapy] — cited by: clinical-trials-landscape.md, systemic-chemotherapy.md

Advanced disease and survivorship

• de Jong MC, et al. Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis. Acta ophthalmologica. 2022;100:e47-e52. PMID 33939299 — tags: [extraocular-metastatic-and-trilateral-disease, guidelines] — cited by: extraocular-metastatic-and-trilateral-disease.md, guidelines.md
• de Bloeme CM, et al. Follow-up of Cystic Pineal Glands in Retinoblastoma Patients Does Not Increase Detection of Pineal Trilateral Retinoblastoma. American journal of ophthalmology. 2024;268:199-211. PMID 38992673 — tags: [extraocular-metastatic-and-trilateral-disease, guidelines, red-flags-and-safety-concerns] — cited by: extraocular-metastatic-and-trilateral-disease.md, guidelines.md, red-flags-and-safety-concerns.md
• Meadows A. Trilateral retinoblastoma. Medical and pediatric oncology. 1986;14:323-6. PMID 3784984 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Limn YS, et al. Trilateral retinoblastoma. The Medical journal of Malaysia. 2011;66:156-7. PMID 22106703 — tags: [extraocular-metastatic-and-trilateral-disease, global-access-and-outcome-disparity] — cited by: extraocular-metastatic-and-trilateral-disease.md, global-access-and-outcome-disparity.md
• Zimmerman LE. "Trilateral retinoblastoma". Journal of pediatric ophthalmology and strabismus. 1983;20:74. PMID 6864422 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Bader JL, et al. Trilateral retinoblastoma. Lancet (London, England). 1980;2:582-3. PMID 6106753 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Menon BS, et al. Extraocular retinoblastoma. Medical and pediatric oncology. 2000;35:75-6. PMID 10881012 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Singh AD, et al. New insights into trilateral retinoblastoma. Cancer. 1999;86:3-5. PMID 10391556 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Larsen S, et al. Trilateral retinoblastoma. Pediatric radiology. 2006;36:82. PMID 16270206 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Mattavelli CCM, et al. Presumed Ectopic Trilateral Retinoblastoma: Case Report. Klinische Monatsblatter fur Augenheilkunde. 2025;242:426-428. PMID 40043725 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Hungerford J. Factors influencing metastasis in retinoblastoma. The British journal of ophthalmology. 1993;77:541. PMID 8218046 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Kaneko A. [Retinoblastoma]. Nihon rinsho. Japanese journal of clinical medicine. 2000;58:1413-8. PMID 10921315 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Kivelä T, et al. Retinoblastoma associated with chromosomal 13q14 deletion mosaicism. Ophthalmology. 2003;110:1983-8. PMID 14522775 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Radhakrishnan V, et al. MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III). The British journal of ophthalmology. 2013;97:52-8. PMID 23117972 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Chantada GL, et al. Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients. JAMA ophthalmology. 2013;131:1127-34. PMID 23787805 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Randhawa JK, et al. The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey. Cancers. 2021;13:4773. PMID 34631159 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Radhakrishnan V, et al. Role of PET/CT in staging and evaluation of treatment response after 3 cycles of chemotherapy in locally advanced retinoblastoma: a prospective study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2012;53:191-8. PMID 22251556 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Batra A, et al. Sirtuin1 Expression and Correlation with Histopathological Features in Retinoblastoma. Ocular oncology and pathology. 2015;2:86-90. PMID 27172132 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Chantada GL, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatric blood & cancer. 2009;52:218-22. PMID 18937327 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Brisse HJ, et al. Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlation. European radiology. 2015;25:1443-52. PMID 25433413 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Kaliki S, et al. Clinical Presentation and Outcomes of Stage III or Stage IV Retinoblastoma in 80 Asian Indian Patients. Journal of pediatric ophthalmology and strabismus. 2017;54:177-184. PMID 27977038 — tags: [extraocular-metastatic-and-trilateral-disease] — cited by: extraocular-metastatic-and-trilateral-disease.md
• Gregersen PA, et al. Incidence and Mortality of Second Primary Cancers in Danish Patients With Retinoblastoma, 1943-2013. JAMA network open. 2020;3:e2022126. PMID 33090227 — tags: [second-cancers-and-survivorship] — cited by: second-cancers-and-survivorship.md
• Chai P, et al. Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Progress in retinal and eye research. 2022;89:101030. PMID 34861419 — tags: [second-cancers-and-survivorship] — cited by: second-cancers-and-survivorship.md
• Murray T. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. Survey of ophthalmology. 1998;43:288-9. PMID 9862317 — tags: [second-cancers-and-survivorship] — cited by: second-cancers-and-survivorship.md
• Fujiwara T, et al. Second primary osteosarcomas in patients with retinoblastoma. Japanese journal of clinical oncology. 2015;45:1139-45. PMID 26438540 — tags: [second-cancers-and-survivorship] — cited by: second-cancers-and-survivorship.md
• Alessio N, et al. Mesenchymal stromal cells having inactivated RB1 survive following low irradiation and accumulate damaged DNA: Hints for side effects following radiotherapy. Cell cycle (Georgetown, Tex.). 2017;16:251-258. PMID 27124644 — tags: [second-cancers-and-survivorship] — cited by: second-cancers-and-survivorship.md
• Fontanesi J, et al. Second malignant neoplasms in children with retinoblastoma: the St. Jude Children's Research Hospital experience. Ophthalmic genetics. 1995;16:105-8. PMID 8556278 — tags: [second-cancers-and-survivorship] — cited by: second-cancers-and-survivorship.md

Global access, vision, guidelines and trials

• Howard SC, et al. The My Child Matters programme: effect of public-private partnerships on paediatric cancer care in low-income and middle-income countries. The Lancet. Oncology. 2018;19:e252-e266. PMID 29726390 — tags: [global-access-and-outcome-disparity] — cited by: global-access-and-outcome-disparity.md
• Dimaras H, et al. Challenging the global retinoblastoma survival disparity through a collaborative research effort. The British journal of ophthalmology. 2010;94:1415-6. PMID 20679076 — tags: [global-access-and-outcome-disparity] — cited by: global-access-and-outcome-disparity.md
• Kaewkhaw R, et al. Retinoblastoma: Etiology, Modeling, and Treatment. Cancers. 2020;12. PMID 32824373 — tags: [global-access-and-outcome-disparity] — cited by: global-access-and-outcome-disparity.md
• Larkin HD. Retinoblastoma Especially Deadly in Children in Low-Income Countries. JAMA. 2022;328:611. PMID 35972479 — tags: [global-access-and-outcome-disparity] — cited by: global-access-and-outcome-disparity.md
• Abramson DH. Retinoblastoma: saving life with vision. Annual review of medicine. 2014;65:171-84. PMID 24422571 — tags: [global-access-and-outcome-disparity] — cited by: global-access-and-outcome-disparity.md
• Chen R, et al. Head and Eye Trauma Before Retinoblastoma Diagnosis. Cancer management and research. 2019;11:10269-10274. PMID 31827335 — tags: [global-access-and-outcome-disparity, red-flags-and-safety-concerns] — cited by: global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md
• Rodriguez-Galindo C, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122:e763-70. PMID 18762512 — tags: [global-access-and-outcome-disparity, red-flags-and-safety-concerns] — cited by: global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md
• Reynolds M, et al. Characterization of vision in pediatric retinoblastoma survivors beyond visual acuity. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2023;27:188.e1-188.e6. PMID 37442536 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Belson PJ, et al. Vision-related quality of life compared to generic measures in retinoblastoma survivors. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2023;32:1095-1105. PMID 36520266 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Morse M, et al. Psychosocial outcomes and quality of life among school-age survivors of retinoblastoma. Pediatric blood & cancer. 2023;70:e29983. PMID 36385462 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Narang S, et al. Unusual presentation of Retinoblastoma. European journal of ophthalmology. 2021;31:NP58-NP60. PMID 32613860 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Farhat W, et al. Advances in biomaterials for the treatment of retinoblastoma. Biomaterials science. 2022;10:5391-5429. PMID 35959730 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Xu J, et al. GD2-CAR-Engineered Microglia Exhibit Antitumor Effects in Organoids and Animal Models of Retinoblastoma. Investigative ophthalmology & visual science. 2025;66:26. PMID 41230904 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Rajput S, et al. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024;59:281-299. PMID 38369298 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Masoomian B, et al. Strabismus management in retinoblastoma survivors. BMC ophthalmology. 2024;24:114. PMID 38481156 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Belson PJ, et al. Health-Related Quality of Life in Adolescent and Young Adult Retinoblastoma Survivors. Journal of pediatric hematology/oncology nursing. 2022;39:342-357. PMID 35674414 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Silvera VM, et al. Retinoblastoma: What the Neuroradiologist Needs to Know. AJNR. American journal of neuroradiology. 2021;42:618-626. PMID 33509920 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Delrish E, et al. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma. Experimental eye research. 2021;204:108423. PMID 33453276 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Leclerc R, et al. An Overview of Retinoblastoma and Enucleation in Pediatric Patients. AORN journal. 2020;111:69-79. PMID 31886534 — tags: [enucleation-and-high-risk-pathology, vision-outcomes-and-patient-experience] — cited by: enucleation-and-high-risk-pathology.md, vision-outcomes-and-patient-experience.md
• Sherief ST, et al. Caring for a child with retinoblastoma: Experience of Ethiopian parents. Pediatric blood & cancer. 2023;70:e30163. PMID 36545916 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Sherief ST, et al. Referral patterns for retinoblastoma patients in Ethiopia. BMC health services research. 2023;23:172. PMID 36803347 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Liu K, et al. Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells. Cell death & disease. 2022;13:521. PMID 35654783 — tags: [vision-outcomes-and-patient-experience] — cited by: vision-outcomes-and-patient-experience.md
• Madan R, et al. Management of Extraocular Retinoblastoma: ICMR Consensus Guidelines. Indian journal of pediatrics. 2024;91:1157-1165. PMID 38639859 — tags: [guidelines] — cited by: guidelines.md
• Ryl T, et al. A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications biology. 2024;7:919. PMID 39079981 — tags: [guidelines] — cited by: guidelines.md
• Zhang R, et al. Automatic retinoblastoma screening and surveillance using deep learning. British journal of cancer. 2023;129:466-474. PMID 37344582 — tags: [guidelines] — cited by: guidelines.md
• Feng H, et al. Human Papillomavirus and Retinoblastoma: Evidence From a Systematic Review and Meta-analysis of Cross-Sectional Studies. International journal of public health. 2023;68:1605284. PMID 37497122 — tags: [guidelines] — cited by: guidelines.md
• Shields JA, et al. Current management of retinoblastoma. Mayo Clinic proceedings. 1994;69:50-6. PMID 8271852 — tags: [guidelines] — cited by: guidelines.md
• Baker MS, et al. Orbital sarcomas in retinoblastoma patients: recommendations for screening and treatment guidelines. Current opinion in ophthalmology. 2016;27:443-8. PMID 27213925 — tags: [guidelines] — cited by: guidelines.md
• Finger PT, et al. Chemotherapy for retinoblastoma: a current topic. Drugs. 1999;58:983-96. PMID 10651386 — tags: [guidelines] — cited by: guidelines.md
• Garin JPL, et al. How we approach conservative treatment of retinoblastoma in South America in the era of local ocular treatments: A consensus of the Grupo America Latina de Oncologia Pediatrica (GALOP). Pediatric blood & cancer. 2023;70:e30352. PMID 37057832 — tags: [guidelines] — cited by: guidelines.md
• de Jong MC, et al. Screening for Pineal Trilateral Retinoblastoma Revisited: A Meta-analysis. Ophthalmology. 2020;127:601-607. PMID 32061409 — tags: [extraocular-metastatic-and-trilateral-disease, guidelines] — cited by: extraocular-metastatic-and-trilateral-disease.md, guidelines.md
• Janic A, et al. Patient-reported outcome measures for retinoblastoma: a scoping review. Journal of patient-reported outcomes. 2020;4:66. PMID 32770435 — tags: [guidelines, vision-outcomes-and-patient-experience] — cited by: guidelines.md, vision-outcomes-and-patient-experience.md
• Mattosinho CCS, et al. Time to diagnosis of retinoblastoma in Latin America: A systematic review. Pediatric hematology and oncology. 2019;36:55-72. PMID 31014139 — tags: [guidelines] — cited by: guidelines.md
• Pascual-Pasto G, et al. Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01. Science translational medicine. 2019;11. PMID 30674657 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Shields CL, et al. Chemoreduction for unilateral retinoblastoma. Archives of ophthalmology (Chicago, Ill. : 1960). 2002;120:1653-8. PMID 12470138 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Russo I, et al. Eye Salvage and Vision Preservation in High-Risk Intraocular Retinoblastoma Patients: Long-Term Results From the Prospective Phase II AIEOP RTB 012 Study. Cancer medicine. 2025;14:e71188. PMID 40891611 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Menon BS, et al. Chemoreduction for intraocular retinoblastoma in Malaysia. Journal of pediatric hematology/oncology. 2007;29:2-4. PMID 17230058 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Wilson MW, et al. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Ophthalmology. 2001;108:2106-14; discussion 2114-5. PMID 11713087 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Antoneli CB, et al. Extraocular retinoblastoma: a 13-year experience. Cancer. 2003;98:1292-8. PMID 12973854 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Sullivan EM, et al. Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation. Journal of pediatric hematology/oncology. 2014;36:e335-40. PMID 24577551 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Saremi L, et al. Parental age-related risk of retinoblastoma in Iranian children. Asian Pacific journal of cancer prevention : APJCP. 2014;15:2847-50. PMID 24761912 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Wang X, et al. Circular RNAs and immunotherapy in retinoblastoma: emerging biomarkers and precision therapeutic strategies. Frontiers in immunology. 2025;16:1666606. PMID 41041300 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Kodetová M, et al. Therapy for Vitreous Seeding Caused by Retinoblastoma. A Review. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2024;80:123-129. PMID 38538290 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Kulbay M, et al. Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances. Biomedicines. 2025;13. PMID 39857692 — tags: [clinical-trials-landscape] — cited by: clinical-trials-landscape.md
• Sherief ST, et al. Clinicopathological Presentation of Retinoblastoma in Ethiopia. Ocular oncology and pathology. 2022;8:168-174. PMID 36938376 — tags: [global-access-and-outcome-disparity, red-flags-and-safety-concerns] — cited by: global-access-and-outcome-disparity.md, red-flags-and-safety-concerns.md